Oramed Pharmaceuticals (ORMP) Free Cash Flow Growth (3y) (2013 - 2026)
Oramed Pharmaceuticals (ORMP) Free Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
24.91% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
20.11% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
14.71% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Oramed Pharmaceuticals |
151.47 Mn |
133.31 Mn |
- |
20.21% |
| Date | Value |
|---|
| Mar 31, 2026 |
20.21% |
| Dec 31, 2025 |
61.76% |
| Sep 30, 2025 |
11.72% |
| Jun 30, 2025 |
25.36% |
| Mar 31, 2025 |
27.32% |
| Nov 30, 2021 |
-18.59% |
| Aug 31, 2021 |
-35.51% |
| May 31, 2021 |
-14.02% |
| Feb 28, 2021 |
1.90% |
| Nov 30, 2020 |
-33.32% |
| May 31, 2020 |
-12.48% |
| Feb 29, 2020 |
-7.45% |
| Nov 30, 2019 |
-58.77% |
| Aug 31, 2019 |
-35.37% |
| May 31, 2019 |
-17.95% |
| Feb 28, 2019 |
-41.12% |
| Nov 30, 2018 |
-22.55% |
| Aug 31, 2018 |
-65.38% |
| May 31, 2018 |
-60.87% |
| Feb 28, 2018 |
-29.41% |
